Precision medicine offers the promise to treat a variety of conditions, especially rare diseases, with targeted approaches. But developing more personalized medicines can introduce new complexities in the clinical trial process, which can hold back drug developers on the road to commercialization. Find out the factors that make rare neurological diseases a prime target for precision medicine, the unique challenges of clinical trials for these conditions, and how choosing the right contract research organization (CRO) can help small and midsize biopharma companies develop these life-changing treatments.
Download the full article below
